Pure Global

Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE) - Trial NCT06380218

Access comprehensive clinical trial information for NCT06380218 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Pasteur de Lille and is currently Recruiting. The study focuses on Healthy Volunteers. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06380218
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06380218
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)

Study Focus

Healthy Volunteers

Nutrional and physical activity program

Interventional

behavioral

Sponsor & Location

Institut Pasteur de Lille

Lille, France

Timeline & Enrollment

N/A

Jul 11, 2023

Aug 01, 2025

50 participants

Primary Outcome

Change from baseline on quality of life of women with cardiovascular risk at 3 months after a nutritional prevention program associated with the consumption of Primevรจre margarine

Summary

The objective is to evaluate the effect of a nutritional prevention program associated with
 the consumption of Primevรจre margarine on the quality of life of women at risk of
 cardiovascular disease after 10 group coaching sessions in nutrition and physical activity.

ICD-10 Classifications

Healthy person accompanying sick person
Routine general health check-up of armed forces
Routine general health check-up of sports teams
Routine general health check-up of inhabitants of institutions

Data Source

ClinicalTrials.gov

NCT06380218

Non-Device Trial